Functions of Polo-Like Kinases: A Journey From Yeast To Humans | Bentham Science
Polo-like kinases: conservation and divergence in their functions and regulation | Nature Reviews Molecular Cell Biology
Switching Polo-like kinase-1 on and off in time and space: Trends in Biochemical Sciences
Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy | Leukemia
Development of a Polo-like Kinase-1 Polo-Box Domain Inhibitor as a Tumor Growth Suppressor in Mice Models | Journal of Medicinal Chemistry
Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centrosomal localization | PNAS
Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment - ScienceDirect
Mitotic Roles of Polo Like Kinase
Figure 2 from Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology. | Semantic Scholar
Autoinhibition and relief mechanism for Polo-like kinase 4 – The Quan Lab
![PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1fab03d33f093b807e4c4dea23eab368e3b4ae0c/3-Figure1-1.png "PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar")
PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar
Late mitotic failure in mice lacking Sak, a polo-like kinase: Current Biology
![PDF] Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/22a093811fa1404a83b7a26e3330d029c694d545/2-Figure1-1.png "PDF] Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology. | Semantic Scholar")
PDF] Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology. | Semantic Scholar
Frontiers | A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas
Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology
The polo-like kinase family. Schematic representation of the five... | Download Scientific Diagram
Polo-like kinase 1 (PLK1) signaling in cancer and beyond - ScienceDirect
![PDF] Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emerging predictive biomarkers | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/495327e5c052f52ad7f69e09b3b220a2ce96ea1a/2-Figure1-1.png "PDF] Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emerging predictive biomarkers | Semantic Scholar")
PDF] Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emerging predictive biomarkers | Semantic Scholar
Cancers | Free Full-Text | The CINs of Polo-Like Kinase 1 in Cancer
Understanding the Polo Kinase machine | Oncogene
Genes | Free Full-Text | The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?
Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential | Journal of Medicinal Chemistry
Polo-like kinases: conservation and divergence in their functions and regulation | Nature Reviews Molecular Cell Biology
Role of polo-like kinase 1 (PLK1) overexpression in cancer. In addition... | Download Scientific Diagram
Peptidomimetics Targeting the Polo-box Domain of Polo-like Kinase 1 | Journal of Emerging Investigators
Polo-like Kinase 1 Licenses CENP-A Deposition at Centromeres - ScienceDirect
Polo-like kinase inhibitors in hematologic malignancies - ScienceDirect
